We demonstrate that the HIF2α-guided metabolic shift in lipid metabolism depends on TCF7L2, and the increased lipid synthesis supports the invasive capacity of ccRCC. This evidence concerns the gene EPAS1 and nonpapillary renal cell carcinoma.